Is the new sodium guideline worth its salt?Amid debate over the optimal intake, hypertension experts raise the daily upper limit Terror worries may slow progress in medical devicesPhysicians say ‘chill’ is affecting manufacturers New U.S. cardiac guidelines cause a ruckus Canadian experts deliver their takes on LDL targets and risk assessment Adempas for chronic thromboembolic pulmonary hypertension First drug approved to treat rare type of pulmonary hypertension. MIs differ in younger women Simple survey in the pharmacy could help heart failure patients Pilot program shows pharmacists could do more in disease management and detection Drug tackles asthma, COPD Airports bad for the heart Stent guidelines need rethink Preventive angioplasty fends off new cardiac events But controversial strategy increases procedure time First Previous 49 50 51 52 53 Next Last
